[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fxLN3MUwXCdr5RPjwZYIDpOj8CHyjOmngWTgoKXPtZbg":3,"$fWJwGKIBBpYIvoQoYZdkF8z0ta2bhNejOnc7ulkWQKmE":32,"$f3Ft0rKFJHppdzE-vuveecxx1BUcg9iOlMLtyzf_MJDg":262},[4,8,12,16,20,24,28],{"title":5,"slug":6,"path":7},"About Microbeonline.com","about-microbeonline-com","\u002Fabout-microbeonline-com\u002F",{"title":9,"slug":10,"path":11},"About Me","about-me","\u002Fabout-microbeonline-com\u002Fabout-me\u002F",{"title":13,"slug":14,"path":15},"Advertise with Us","advertise-us","\u002Fadvertise-us\u002F",{"title":17,"slug":18,"path":19},"Privacy Policy","privacy-policy","\u002Fprivacy-policy\u002F",{"title":21,"slug":22,"path":23},"Abbreviations","abbreviations","\u002Fabbreviations\u002F",{"title":25,"slug":26,"path":27},"Microbes","microbes","\u002Fmicrobes\u002F",{"title":29,"slug":30,"path":31},"Books","recommended-books","\u002Frecommended-books\u002F",{"type":33,"data":34},"blog",{"slug":35,"title":36,"description":37,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":40,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"body":44,"faq":45,"tags":64,"related":66},"antigen-antibody-reactions","Antigen-Antibody Reactions: Types, Stages, and How Each Is Used","The full framework of antigen-antibody reactions: the three stages of binding, and the main reaction types (agglutination, precipitation, complement fixation, neutralization, and labeled immunoassays), with what each detects and where it is used.",null,"Acharya Tankeshwar","2010-04-20","2026-07-20",false,"immunology","An antigen-antibody reaction is the specific binding of an antibody to the antigen that stimulated its production. This single interaction is the basis of both the body's humoral defense and almost every serological test in the diagnostic laboratory. The reaction can be made to reveal itself in many ways, as clumping, as a visible precipitate, as the consumption of complement, as the blocking of a toxin, or as a fluorescent or colored signal, and each of those visible outcomes is the basis of a different family of tests. This article is the map of that landscape: the stages every antigen-antibody reaction passes through, the main reaction types, and what each one is used to detect. Each type links to a dedicated article for its full method.\n\nAn antigen-antibody reaction, also known as an antibody-antigen interaction or antigen-antibody binding, is a specific molecular interaction between an antigen and an antibody. Antigens are molecules or molecular structures often found on the surface of pathogens like bacteria, viruses, and other foreign substances, as well as on the surface of cells in the body. Antibodies or immunoglobulins are Y-shaped proteins formed by the immune system as a response to the presence of antigens.\n\n### General feature of antigen-antibody reactions\n\n1. The reaction is **specific**; an antigen combines only with its homologous antibody and vice versa. The specificity however is not absolute and cross-reactions may occur due to antigenic similarity or relatedness.\n2. Whole antibody and antigen molecules take part in the reaction under normal conditions, though isolated antibody fragments (Fab) also retain antigen-binding ability.\n3. There is no denaturation of the antigen or the antibody during the reaction.\n4. The combination occurs at the surface, therefore it is the surface antigens that are immunologically relevant.\n5. The binding is non-covalent and therefore reversible. It is held by hydrogen bonds, ionic bonds, hydrophobic interactions, and van der Waals forces rather than covalent bonds, and its strength is described by affinity and avidity. Reversibility matters in practice: it is what allows bound antibody to be eluted from red cells, and it is why binding strength, not permanence, is what determines whether a reaction becomes visible.\\\n   \\\n   The strength of the interaction is measured as affinity (the fit between a single epitope and paratope) and avidity (the combined strength of all binding sites acting together). For a full treatment, see [affinity vs avidity](\u002Fantibody-affinity-vs-antibody-avidity\u002F).\n6. Antigens and antibodies can combine in varying proportions, unlike chemicals with fixed valencies. Both antigens and antibodies are multivalent, antibodies are generally bivalent, though **IgM molecules may have five or ten combining sites**. Antigens may have valencies up to hundreds.\n\n## The three stages of an antigen-antibody reaction\n\nEvery antigen-antibody reaction passes through the same sequence, and different tests simply read it at different points.\n\n**Primary stage.** The initial binding of antigen to antibody. It is rapid, reversible, and held by non-covalent forces. On its own it is invisible; specialized labeled techniques (immunofluorescence, ELISA, radioimmunoassay) are needed to detect binding at this stage.\n\n**Secondary stage.** The bound complexes build into something visible: clumping (agglutination), an insoluble mass (precipitation), complement consumption (complement fixation), or loss of biological activity (neutralization). Most classical serological tests read the secondary stage. Note that the binding is still non-covalent here; the reaction becomes visible because many complexes aggregate into a lattice, not because the bonds change nature.\n\n**Tertiary stage.** The in-vivo consequences of binding: neutralization of toxins, enhanced phagocytosis, cell lysis, and both protective immunity and immunopathology (allergy, immune-complex disease).\n\n## Prozone Phenomenon\n\nAt high antibody concentrations, the number of antibody binding sites may greatly exceed the number of epitopes present in the antigens. As a result, most antibodies bind antigen only univalent instead of multivalently. Antibodies that bind univalent can not cross-link one antigen to another.\n\n![Prozone phenomenon - ](\u002Fblogs\u002FThe-ratio-of-antigen-and-antibody.jpg)Figure: Prozone phenomenon -\n\nProzone effects are readily diagnosed by performing the assay at a variety of antibody ( or antigen) concentrations. As one dilutes to an optimum antibody concentration, one sees higher levels of agglutination. When using polyclonal antibodies incomplete antibodies also cause a prozone effect.\n\nThe mirror situation, antigen excess, is called the postzone, and it too can suppress a visible reaction. Both are why serological tests are run across a dilution series rather than at a single concentration. The zone of optimal proportions between them is the equivalence zone.\n\n## Types of antigen-antibody reactions\n\n![ - Fig. (a).Tube agglutination test for determining antibody titer.](https:\u002F\u002Fi0.wp.com\u002F2.bp.blogspot.com\u002F\\_cCU1vJAsuTc\u002FS80ffufgK2I\u002FAAAAAAAAAeA\u002FtC8gPgp__Rk\u002Fs400\u002FNew%2BPicture%2B%285%29.png?w=640)Fig: Tube agglutination test for the determination of antibody titer\n\n### Agglutination\n\nAntibody cross-links particle-bound antigen (bacteria, red cells, or antigen-coated latex beads) into visible clumps. It is more sensitive than precipitation for detecting antibody, and it is read by eye without instruments. Slide, tube, latex, coagglutination, hemagglutination, and inhibition formats each have their place. For the full taxonomy and clinical examples, see [Agglutination test types](\u002Fagglutination-types\u002F). Specific applications have their own articles: [Widal test](\u002Fwidal-test-principle-procedure-results\u002F), [Coombs test](\u002Fcoombs-test-types-principle-results\u002F), and the treponemal [TPHA](\u002Ftpha-principle-procedure-results-and-interpretations\u002F).\n\n![Widal Test: Sample showing H positive in screening test - Widal Test: Sample showing H positive in screening test](\u002Fblogs\u002Fsample-showing-H-positive-in-screening-test.jpg)Figure: Widal Test: Sample showing H positive in screening test\n\n### Precipitation\n\nWhen a *soluble* antigen combines with antibody in optimal proportions, the complexes grow into an insoluble, visible precipitate. Precipitation is most efficient at the zone of equivalence, where antigen and antibody are balanced. It underlies immunodiffusion (Ouchterlony, radial immunodiffusion) and electrophoretic methods such as [counterimmunoelectrophoresis (CIE)](\u002Fserologic-methods-counterimmunoelectrophoresis-cie\u002F).\n\n### Complement fixation\n\nSome antigen-antibody complexes bind (fix) complement. This is exploited in the complement fixation test, where consumption of complement by a test reaction is revealed by the absence of lysis in an indicator system. See [Complement fixation test](\u002Fcomplement-fixation-test-principle-procedure-results\u002F).\n\n### Neutralization\n\nAntibody binds an antigen in a way that blocks its biological activity, neutralizing the toxicity of a toxin or the infectivity of a virus. This is the basis of toxin-neutralization and virus-neutralization assays. See [Neutralization test (virus and toxins)](\u002Fneutralization-test-virus-toxins\u002F).\n\n### Labeled immunoassays\n\nAttaching a detectable label to antibody or antigen makes even primary-stage binding visible. The label may be a fluorophore (immunofluorescence), an enzyme (ELISA), or a radioisotope (radioimmunoassay). See [Immunofluorescence assay](\u002Fimmunofluorescence-assay\u002F) and [ELISA](\u002Felisa-test-for-antigenantibody-detection\u002F).\n\n### How to Remember\n\nTwo devices for the two things the hub is meant to lock in.\n\n**Three stages, three visibilities.** Primary binding is invisible (you need a label to see it, so labeled assays live here). Secondary binding is visible as clumps or precipitates (classical serology lives here). Tertiary is what happens in the body (protection and immunopathology). Match the stage to how you would detect it.\n\n**The reaction type is named for what you see.** Clump = agglutination. Insoluble mass = precipitation. Complement used up = complement fixation. Activity blocked = neutralization. Glow or color = labeled immunoassay. Name the visible outcome and you have named the reaction type.\n\n### Key exam facts in one table\n\n| Point | What to remember |\n| --- | --- |\n| Binding forces | Non-covalent: hydrogen, ionic, hydrophobic, van der Waals |\n| Reversibility | The binding is reversible (not covalent, not permanent) |\n| Specificity | High, but not absolute; cross-reaction occurs with related antigens |\n| Affinity vs avidity | Affinity = single-site fit; avidity = combined strength of all sites (see dedicated article) |\n| Primary stage | Invisible binding; detected only by labeled assays (IFA, ELISA, RIA) |\n| Secondary stage | Visible: agglutination, precipitation, complement fixation, neutralization |\n| Tertiary stage | In-vivo effects: neutralization, opsonization, lysis, immunopathology |\n| Agglutination | Particle-bound antigen clumps; more sensitive than precipitation for antibody |\n| Precipitation | Soluble antigen forms insoluble mass; best at equivalence |\n| Prozone | Antibody excess blocks visible reaction → false negative |\n| Postzone | Antigen excess blocks visible reaction → false negative |\n| Equivalence | Optimal antigen:antibody proportions; maximal visible reaction |\n\n### Where students get confused\n\n**\"Antigen-antibody binding is irreversible.\"** It is not. The binding is non-covalent and reversible. What looks permanent is a large, stable lattice of many complexes, but each individual bond can form and break. This reversibility is exactly what elution techniques exploit.\n\n**\"The secondary stage uses covalent bonds because it's stable.\"** A common textbook error. The bonds are non-covalent at every stage. The secondary stage is visible because complexes aggregate into a lattice, not because the chemistry changes.\n\n**\"Agglutination and precipitation are basically the same.\"** Both are the antigen-antibody lattice becoming visible, but agglutination needs a *particulate* antigen (or one coated on a particle) and precipitation needs a *soluble* antigen. Agglutination is also generally more sensitive for detecting small amounts of antibody.\n\n**\"A stronger reaction always means more antibody.\"** Antibody excess (prozone) can *suppress* a visible reaction, and antigen excess (postzone) does the same. Maximal reaction occurs at equivalence, in the middle, which is why serology is read across dilutions.\n\n### References\n\n- Levinson, W. (2020). *Review of Medical Microbiology and Immunology* (16th ed.). McGraw-Hill.\n- Tille, P. M. (2022). *Bailey & Scott's Diagnostic Microbiology* (15th ed.). Elsevier.\n- Procop, G. W., et al. (2017). *Koneman's Color Atlas and Textbook of Diagnostic Microbiology* (7th ed.). Wolters Kluwer.\n- Murphy, K., & Weaver, C. (2016). *Janeway's Immunobiology* (9th ed.). Garland Science.",[46,49,52,55,58,61],{"question":47,"answer":48},"What is an antigen-antibody reaction?","It is the specific binding of an antibody to the antigen that induced its formation. This binding is the basis of humoral immunity and of the serological tests used to diagnose infection and identify organisms.",{"question":50,"answer":51},"Is antigen-antibody binding reversible?","Yes. The binding is held by non-covalent forces (hydrogen bonds, ionic bonds, hydrophobic interactions, van der Waals forces) and is reversible. It is not a covalent, permanent bond.",{"question":53,"answer":54},"What are the three stages of an antigen-antibody reaction?","The primary stage is the initial, invisible binding. The secondary stage produces visible effects such as agglutination, precipitation, complement fixation, and neutralization. The tertiary stage covers the in-vivo consequences, including protection and immunopathology.",{"question":56,"answer":57},"What is the difference between agglutination and precipitation?","Agglutination requires a particulate antigen (or a soluble antigen coated onto a particle) and produces visible clumps. Precipitation requires a soluble antigen and produces an insoluble visible mass. Agglutination is generally more sensitive for detecting antibody.",{"question":59,"answer":60},"What is the prozone phenomenon?","When antibody is present in large excess, it cannot cross-link antigen efficiently and no visible reaction occurs, producing a false-negative. Antigen excess causes the same problem (postzone). Testing serial dilutions reveals the true result, which is strongest at equivalence.",{"question":62,"answer":63},"What are the main types of antigen-antibody reactions?","Agglutination, precipitation, complement fixation, neutralization, and labeled immunoassays (immunofluorescence, ELISA, radioimmunoassay). Each is the basis of a different family of diagnostic tests.",[65],"immunoassays",[67,93,118,144,170,195,220,228],{"slug":68,"title":69,"description":70,"seoTitle":38,"seoDescription":38,"author":71,"createdDate":72,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"faq":73,"tags":92},"determination-of-blood-group","Blood Grouping (ABO and Rh): Forward vs Reverse Typing and How to Interpret","How ABO and Rh blood grouping works: forward (cell) versus reverse (serum) typing, why the two must agree, the Bombay phenotype trap, and how agglutination gives the result. Procedure and interpretation included.","Ashma Shrestha","2023-08-30",[74,77,80,83,86,89],{"question":75,"answer":76},"What is the difference between forward and reverse blood grouping?","Forward (cell) grouping tests the patient's red cells with known anti-A and anti-B sera to find which antigens are present. Reverse (serum) grouping tests the patient's serum against known A and B cells to find which antibodies are present. The two must agree; if they do not, it is an ABO discrepancy that must be investigated.",{"question":78,"answer":79},"Why is reverse grouping necessary if forward grouping already gives the blood group?","Because it is a built-in safety check. Forward and reverse results should mirror each other, and a disagreement flags weak antigens, unexpected antibodies, or rare phenotypes such as Bombay. Reporting a group from forward typing alone can be dangerous.",{"question":81,"answer":82},"What is the Bombay blood group?","A rare phenotype that lacks the H antigen, so the cells carry no A, B, or H antigen. On forward typing it looks like group O, but the serum contains anti-H that agglutinates ordinary O cells. Bombay patients can only receive Bombay blood, so recognizing it is critical.",{"question":84,"answer":85},"Is there a \"d\" antigen in the Rh system?","No. Rh-negative simply means the D antigen is absent. Lowercase \"d\" is only a way of writing \"no D,\" not an antigen that can be detected.",{"question":87,"answer":88},"Why is anti-D not naturally present in Rh-negative people?","Unlike anti-A and anti-B, which occur naturally, anti-D forms only after an Rh-negative person is exposed to Rh-positive red cells, through transfusion or pregnancy. This is why Rh-negative mothers are given anti-D immunoglobulin to prevent sensitization.",{"question":90,"answer":91},"Which blood group is the universal donor?","Group O red cells are the universal red cell donor because they carry no A or B antigen. For plasma, group AB is the universal donor because AB plasma has no anti-A or anti-B. The direction differs for cells versus plasma.",[65],{"slug":94,"title":95,"description":96,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":97,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"faq":98,"tags":117},"radioimmunoassay-principle-use-limitation","Radioimmunoassay (RIA): The Competitive Principle (More Antigen, Less Signal)","How radioimmunoassay measures tiny amounts of antigen: labeled and unlabeled antigen compete for limited antibody, so the radioactive signal falls as the sample's antigen rises. Principle, procedure, RIA vs ELISA, and limitations.","2020-06-11",[99,102,105,108,111,114],{"question":100,"answer":101},"What is the principle of radioimmunoassay?","RIA is based on competition. A fixed, limited amount of antibody is offered both a fixed amount of radiolabeled antigen and the unknown unlabeled antigen from the sample. The two compete for the antibody, and the amount of labeled antigen that ends up bound is measured as radioactivity.",{"question":103,"answer":104},"Why does more antigen give a lower signal in RIA?","Because the patient's unlabeled antigen competes the labeled antigen away from the limited antibody sites. The more antigen in the sample, the less labeled antigen stays bound, so the bound radioactivity falls. The signal is inversely proportional to the antigen concentration.",{"question":106,"answer":107},"Which radioisotopes are used in RIA?","Most commonly iodine-125, and sometimes tritium (3H). The isotope labels the reagent antigen, and its radioactivity is measured with a gamma or scintillation counter.",{"question":109,"answer":110},"What is the difference between RIA and ELISA?","Both use the same competitive principle, but RIA uses a radioactive label read as radioactivity, while ELISA uses an enzyme label read as a color change. ELISA has replaced RIA in most routine laboratories because it avoids radiation hazard while giving comparable sensitivity.",{"question":112,"answer":113},"What is the difference between RIA and IRMA?","RIA is competitive and uses a labeled antigen, so the signal is inversely proportional to the antigen concentration. IRMA is non-competitive and uses a labeled antibody to sandwich the antigen, so its signal is directly proportional to the antigen concentration.",{"question":115,"answer":116},"Why has RIA been largely replaced?","Because of the hazards and inconvenience of radioactivity: safety precautions, licensing, radioactive waste disposal, and short reagent shelf life. ELISA and other non-radioactive assays match its performance without these problems.",[65],{"slug":119,"title":120,"description":121,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":122,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"faq":123,"tags":142},"indirect-fluorescent-antibody-ifa-test","Indirect Fluorescent Antibody (IFA) Test: Principle, Procedure, and Uses","How the indirect fluorescent antibody (IFA) test uses two antibodies to detect antibodies in patient serum (and antigens in cells). Principle, procedure, syphilis example, and why the indirect design amplifies the signal.","2020-06-09",[124,127,130,133,136,139],{"question":125,"answer":126},"What does the indirect fluorescent antibody (IFA) test detect?","Most often it detects specific antibodies in a patient's serum or CSF, for example antibodies against the agents of rabies, syphilis, toxoplasmosis, leishmaniasis, or legionellosis. The same two-antibody design can also detect antigens in cells.",{"question":128,"answer":129},"Why does IFA use two antibodies?","A patient's own antibody carries no fluorescent label and cannot be seen. IFA adds a second, labeled antibody directed against human immunoglobulin, which binds the patient's antibody and makes it visible. Because several labeled secondary antibodies bind each primary, the signal is amplified.",{"question":131,"answer":132},"Why is IFA more sensitive than DFA?","In IFA, multiple labeled secondary antibodies stack onto each primary antibody, multiplying the fluorescent signal. The direct method (DFA) uses a single labeled antibody, so its signal is not amplified.",{"question":134,"answer":135},"What is the difference between IFA and FTA-ABS?","FTA-ABS is a specific application of indirect immunofluorescence used to confirm syphilis. It adds an absorption step to remove antibodies that cross-react with non-pathogenic treponemes, improving specificity.",{"question":137,"answer":138},"What colors are seen in an IFA test?","FITC-labeled antibody produces apple-green (sometimes called yellow-green) fluorescence, and rhodamine-labeled antibody produces red. A positive result is the specific glow at the site where antibody has bound.",{"question":140,"answer":141},"Is IFA quantitative?","It is semi-quantitative. By testing serial dilutions of the patient's serum, the laboratory can estimate an antibody titer, which is useful for judging the strength of a response or following it over time.",[65,143],"immunofluorescence",{"slug":145,"title":146,"description":147,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":148,"lastUpdatedDate":149,"draft":42,"category":43,"image":38,"faq":150,"tags":169},"direct-fluorescent-antibody-dfa-test","Direct Fluorescent Antibody (DFA) Test: Principle, Procedure, and Clinical Uses","How the direct fluorescent antibody (DFA) test detects antigen directly in a specimen using one labeled antibody. Principle, step-by-step procedure, apple-green result, and the key clinical uses (rabies, RSV, Legionella, chlamydia)","2019-11-18","2026-07-19",[151,154,157,160,163,166],{"question":152,"answer":153},"What does a direct fluorescent antibody (DFA) test detect?","It detects a specific antigen present directly in a specimen, such as a virus or bacterium, using a single antibody that is already labeled with a fluorescent dye. It does not detect antibodies in the patient's blood.",{"question":155,"answer":156},"What does a positive DFA result look like?","Areas where the target antigen is present glow apple-green under a fluorescence microscope. A negative result shows no fluorescence or only faint nonspecific background.",{"question":158,"answer":159},"Why is DFA used for rabies diagnosis?","The rabies virus is difficult to culture, and a rapid answer is critical for public health decisions. DFA detects rabies antigen directly in brain tissue and is the reference (gold-standard) test for post-mortem rabies diagnosis.",{"question":161,"answer":162},"What is the difference between DFA and IFA?","DFA (direct) uses one labeled antibody that binds the antigen in a single step. IFA (indirect) uses an unlabeled primary antibody followed by a labeled secondary antibody, which amplifies the signal. DFA is faster; IFA is generally more sensitive.",{"question":164,"answer":165},"Does DFA need a UV microscope?","No. The common fluorophore FITC is excited by blue light and emits green. A fluorescence microscope with the correct filter set is required, not specifically a UV lamp.",{"question":167,"answer":168},"Why must DFA slides be read promptly?","Fluorescent dyes photobleach, meaning the signal fades with time and light exposure. Slides do not archive well and should be examined soon after staining.",[65,143],{"slug":171,"title":172,"description":173,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":174,"lastUpdatedDate":149,"draft":42,"category":43,"image":38,"faq":175,"tags":194},"antigens-in-disease-diagnosis","Antigen Detection Tests for Disease Diagnosis: Methods, Examples, and Clinical Uses","Antigen detection tests identify pathogen proteins directly in blood, urine, stool, or CSF before antibodies appear. Learn the methods (ELISA, RDT, immunofluorescence, latex agglutination), key antigens (NS1, HBsAg, p24, HRP2, Cryptococcal), and when antigen testing beats serology.","2019-10-22",[176,179,182,185,188,191],{"question":177,"answer":178},"Why is the dengue NS1 antigen test only useful in the first seven days of illness?","The NS1 (non-structural protein 1) antigen is produced and secreted at high concentrations by dengue virus-infected cells during active viral replication. During the first 1–7 days of dengue illness, viraemia is high and NS1 is detectable in blood at concentrations well above the detection limits of commercial RDTs and ELISA kits. After approximately day 7, viral replication decreases as the immune response mounts, and simultaneously, immune complexes between anti-NS1 antibodies and the NS1 protein form, removing free NS1 from circulation. The NS1 concentration in blood falls below the detection threshold of most assays by day 7–9. After this point, dengue serology (IgM and IgG) becomes the appropriate test. The practical implication is that a negative NS1 test after day 7 does not exclude dengue infection — the antigen has been cleared by the immune response even if the patient is still symptomatic. Conversely, NS1 testing is particularly valuable in the first few days of illness when IgM has not yet appeared and serology would also be negative.",{"question":180,"answer":181},"What is the clinical significance of Cryptococcal antigen detection in HIV-positive patients?","Cryptococcal meningitis caused by Cryptococcus neoformans is the most common cause of meningitis in HIV-positive adults in Sub-Saharan Africa and Southeast Asia, accounting for 15–20% of AIDS-related deaths globally. In patients with CD4 counts below 100 cells\u002FµL, C. neoformans can disseminate from a pulmonary focus to the CNS before causing obvious clinical symptoms. WHO recommends routine Cryptococcal antigen (CrAg) screening using the lateral flow assay (LFA) in all HIV-positive patients with CD4 \u003C100 cells\u002FµL, regardless of symptoms. The CrAg LFA has sensitivity and specificity both exceeding 99% for cryptococcal meningitis, costs under $5 per test, and requires no laboratory equipment or refrigeration. A positive CrAg screen in an asymptomatic patient triggers diagnostic lumbar puncture and early pre-emptive antifungal treatment with fluconazole — before the patient develops severe meningitis. Studies have demonstrated that systematic CrAg screening with pre-emptive treatment reduces 10-week mortality by approximately 28% compared to waiting for symptomatic presentation. This is one of the most clinically impactful applications of antigen detection in resource-limited settings.",{"question":183,"answer":184},"Why do malaria HRP2-based RDTs sometimes remain positive after the parasites have been cleared by treatment?","HRP2 (histidine-rich protein 2) is a protein secreted specifically by Plasmodium falciparum asexual and sexual stage parasites. Unlike pLDH (parasite lactate dehydrogenase), which is an enzyme expressed only during active metabolism and clears from the blood within 24–48 hours after parasite death, HRP2 is a secreted protein that accumulates in the bloodstream and is cleared much more slowly — over days to weeks — by normal protein degradation processes. After successful antimalarial treatment that kills all parasites, HRP2 levels decline gradually but may remain detectable by RDT for up to 4 weeks after clinical and parasitological cure. This persistence means that HRP2-based RDTs cannot be reliably used to confirm treatment response or diagnose re-infection within one month of a previous falciparum infection. For test-of-cure in clinical trials and treatment monitoring programmes, pLDH-based RDTs or blood film microscopy are preferred because they reflect current parasitaemia rather than residual antigen from a cleared infection.",{"question":186,"answer":187},"Why does antigen testing detect infection earlier than antibody testing?","Antigen is part of the pathogen itself and is present from the moment of infection; antibodies take days to weeks for the immune system to produce, creating a window period where only antigen tests are positive.",{"question":189,"answer":190},"Why is serology not used to confirm H. pylori eradication?","Anti-H. pylori IgG can remain elevated for months to years after successful treatment, so it cannot distinguish active from past infection. Stool antigen testing or the urea breath test is used instead.",{"question":192,"answer":193},"Does a negative Legionella urinary antigen test rule out Legionnaires' disease?","No. The test detects only serogroup 1, which accounts for roughly 80% of cases; the remaining 20% caused by other serogroups will test negative despite active infection.",[65],{"slug":196,"title":197,"description":198,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":199,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"faq":200,"tags":219},"coombs-test-types-principle-results","Coombs Test: Direct vs Indirect (DAT vs IAT), and How to Interpret Results","The Coombs (antiglobulin) test explained: why direct detects antibody already on the patient's red cells and indirect detects antibody in serum, what a positive DAT means (warm vs cold AIHA), and where each test is used.","2019-05-04",[201,204,207,210,213,216],{"question":202,"answer":203},"What is the difference between direct and indirect Coombs tests?","The direct test (DAT) checks the patient's red cells for antibody that has already coated them in the body. The indirect test (IAT) checks the patient's serum for antibody that could coat red cells, by first mixing the serum with test cells. Direct tests cells; indirect tests serum.",{"question":205,"answer":206},"What does a positive direct Coombs test mean?","It means the patient's red cells are coated with antibody or complement. Depending on the clinical picture, this points to autoimmune hemolytic anemia, hemolytic disease of the newborn, or a transfusion reaction. A positive result alone does not prove active hemolysis; it must be read with hemolysis markers.",{"question":208,"answer":209},"Why can't incomplete (IgG) antibodies agglutinate red cells on their own?","Red cells carry a negative surface charge that holds them about 20 nm apart, and IgG's binding arms are too short to bridge that distance. The Coombs reagent (antihuman globulin) supplies the bridge, linking IgG-coated cells into visible clumps.",{"question":211,"answer":212},"What is the Coombs reagent made of?","It is antihuman globulin. The polyspecific reagent contains anti-IgG and anti-C3d (a complement fragment). If a test is positive, monospecific anti-IgG and anti-C3d reagents are used to determine exactly what is coating the cells.",{"question":214,"answer":215},"Where is the indirect Coombs test used?","In crossmatching before transfusion, in antibody screening, and in prenatal testing to detect maternal antibodies that could harm the fetus.",{"question":217,"answer":218},"Why must red cells be washed during the test?","Washing removes free, unbound immunoglobulin. If it is left in, it would bind and neutralize the antihuman globulin reagent before it can bridge the cells, producing a false negative.",[65],{"slug":221,"title":222,"description":223,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":224,"lastUpdatedDate":225,"draft":42,"category":43,"image":38,"faq":226,"tags":227},"antibodies-disease-diagnosis","Serological Tests for Disease Diagnosis: A Complete Guide to Antibody Detection","Serological tests detect antibodies or antigens in patient serum to diagnose infections. This hub covers interpretation principles, seroconversion, the 9 key infections diagnosed serologically, all major test methods (ELISA, ICT, HAI, CFT, RIA, IFA), and links to detailed procedure articles for each test.","2019-02-01","2026-07-06",[],[65],{"slug":229,"title":230,"description":231,"seoTitle":232,"seoDescription":233,"author":39,"createdDate":234,"lastUpdatedDate":235,"draft":42,"category":43,"image":38,"faq":236,"tags":261},"widal-test-principle-procedure-results","Widal Test: How to Read Titers Against a Local Baseline (with Nepal Data)","Widal test: principle, slide and tube procedure, result interpretation, diagnostic titers by region, false positives, limitations, and comparison with newer typhoid diagnostic tests. Includes Nepal-specific baseline titer data.","Widal Test: Procedure, Titers, Interpretation, and Limitations","Review Widal test antigen reactions, slide and tube procedures, regional titer interpretation, timing, limitations, and frequent causes of false results.","2015-12-01","2026-07-18",[237,240,243,246,249,252,255,258],{"question":238,"answer":239},"What is the significant titer for a positive Widal test?","No universal threshold — depends on local endemicity. Nepal baseline (Acharya T et al., JHAS 2013): anti-O >1:80, anti-H >1:160. Fourfold rise between acute and convalescent samples is the most reliable criterion.",{"question":241,"answer":242},"What is the difference between O and H agglutination?","O: somatic antigen, compact granular clumps, day 6-8, declines early — marker for active infection. H: flagellar antigen, large fluffy clumps, day 10-12, persists long — may reflect past infection or vaccination.",{"question":244,"answer":245},"Why can the Widal test be falsely positive?","Previous typhoid vaccination, past subclinical infection in endemic areas, cross-reactions with malaria, liver disease, and other Salmonella serotypes all cause false positives.",{"question":247,"answer":248},"Can the Widal test be negative in proven typhoid?","Yes — antibiotics taken before testing, testing too early (before day 6-8), immunocompromised patient, or Vi antigen interference. A negative Widal does not exclude typhoid.",{"question":250,"answer":251},"Why must baseline titers be established locally?","Endemic populations have raised background titers from subclinical exposures. Nepal research (Acharya T et al., JHAS 2013): >1:80 for anti-O and >1:160 for anti-H diagnostically significant based on 490 healthy donors.",{"question":253,"answer":254},"Is the Widal test still recommended?","Widely used in resource-limited settings. Variable sensitivity (47-77%) and specificity (50-92%). Typhidot and Tubex TF offer better specificity. Blood culture is gold standard. Widal useful with clinical judgment and local baseline titers.",{"question":256,"answer":257},"What is the best time to perform the Widal test?","Second week of illness — O antibodies day 6-8, H antibodies day 10-12. First week testing gives false negatives. Paired acute and convalescent samples with fourfold rise is gold standard.",{"question":259,"answer":260},"What does positive AH or BH mean?","AH = Salmonella Paratyphi A flagellar antigen = paratyphoid fever A. BH = Salmonella Paratyphi B = paratyphoid fever B. Cross-reactivity with H antigen can occur.",[65],[263,269,275,280,284,288,293,298,302,306],{"slug":264,"name":39,"description":265,"image":266,"body":267,"postCount":268},"acharya-tankeshwar","Editor-in-chief","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Ftankeshwar-acharya-author-microbeonline.jpg","***Tankeshwar Acharya, MSc (Medical Microbiology)***\n\n*Tankeshwar Acharya is an Assistant Professor in the Department of Microbiology at Patan Academy of Health Sciences (PAHS), Nepal, where he has been teaching and practicing clinical microbiology for over 14 years. He is the founder of Microbe Online, one of the leading free microbiology education resources on the web, covering bacteriology, mycology, parasitology, immunology, and clinical laboratory diagnostics written from direct experience in both the classroom and the diagnostic laboratory.*",433,{"slug":270,"name":71,"description":271,"image":272,"body":273,"postCount":274},"ashma-shrestha","SEO Copywriter and Science Communicator\nKathmandu, Nepal","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Fashma-shrestha.png","Ashma Shrestha holds a Master of Science in Medical Microbiology from the Institute of Science and Technology (IOST), Tribhuvan University, Nepal, where she developed a strong foundation in virology, molecular biology, and diagnostic microbiology.\n\nShe now works as an SEO Copywriter at Resolution Digital, where she combines her scientific training with research-driven content strategy. She is certified in Google Analytics and Google Business Profile (GBP), and brings a data-informed approach to science communication writing content that is not only accurate but structured to reach and serve the students who need it most.\n\nAt microbeonline, Ashma contributes articles primarily in virology and molecular biology, areas she finds most compelling for their mechanistic depth and their growing clinical relevance. Her writing reflects the same standard the site is built on: factual rigor, clear explanation of the *why* behind microbiology concepts, and content that helps students move from memorization to genuine understanding.\n\nShe is passionate about making complex microbiological concepts accessible without sacrificing accuracy; a skill that sits at the intersection of her scientific training and her professional work in content and SEO.",81,{"slug":276,"name":277,"description":278,"image":38,"body":38,"postCount":279},"sushmita-baniya","Sushmita Baniya","Author \u002F Contributor",32,{"slug":281,"name":282,"description":278,"image":38,"body":38,"postCount":283},"samikshya-acharya","Samikshya Acharya",20,{"slug":285,"name":286,"description":278,"image":38,"body":38,"postCount":287},"alisha-tripathi","Alisha Tripathi",6,{"slug":289,"name":290,"description":291,"image":38,"body":38,"postCount":292},"aastha-shrestha","Aastha Shrestha"," Author \u002F Contributor",10,{"slug":294,"name":295,"description":296,"image":38,"body":38,"postCount":297},"guest-author","Guest Author","Guest Author \u002F Contributor",2,{"slug":299,"name":300,"description":278,"image":38,"body":38,"postCount":301},"srijana-khanal","Srijana Khanal",18,{"slug":303,"name":304,"description":296,"image":38,"body":38,"postCount":305},"dr-poonam-acharya","Dr. Poonam Acharya",1,{"slug":307,"name":308,"description":278,"image":38,"body":309,"postCount":310},"nisha-rijal","Nisha Rijal","**Nisha Rijal** is a microbiologist and quality assurance specialist. She served for nearly 12 years as a microbiologist at the National Public Health Laboratory (NPHL), Nepal's national reference laboratory, and continues to work as a consultant microbiologist in international public health organization. ",51]